Method development for determination of imatinib and its major metabolite, N ‐desmethyl imatinib, in biological and environmental samples by SA–SHS

Method development for determination of imatinib and its major metabolite, N ‐desmethyl imatinib, in biological and environmental samples by SA–SHS–LPME and HPLC

Published:2021-02-25 Issue:7 Volume:35 Page:
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Rahimi Kakavandi Nader¹²^ORCID,Asadi Tayebeh³⁴,Jannat Behrouz⁵,Abdi Khosrou⁶⁷^ORCID,Ghazi‐Khansari Mahmoud⁸^ORCID,Shahali Hossein⁹,Naraki Karim⁸

Affiliation:

1. Department of Toxicology and Pharmacology, Faculty of Pharmacy Tehran University of Medical Sciences Tehran Iran

2. Students' Scientific Research Center Tehran University of Medical Sciences Tehran Iran

3. Department of Toxicology and Pharmacology, School of Pharmacy Hamadan University of Medical Sciences Hamadan Iran

4. Students Research Center Hamadan University of Medical Sciences Hamadan Iran

5. Halal Research Center of IRI FDA Iran

6. Department of Radiopharmacy and Medicinal Chemistry, Faculty of Pharmacy Tehran University of Medical Sciences Tehran Iran

7. Iranian National Center for Addiction Studies Tehran University of Medical Sciences Tehran Iran

8. Department of Pharmacology, School of Medicine Tehran University of Medical Sciences Tehran Iran

9. School of Metallurgy and Materials Engineering, College of Engineering University of Tehran Tehran Iran

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bmc.5088

Reference39 articles.

1. Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS

2. Simultaneous determination of nilotinib, imatinib and its main metabolite (CGP-74588) in human plasma by ultra-violet high performance liquid chromatography

3. Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome

4. Monitoring of antifungal drugs in biological samples using ultrasonic-assisted supramolecular dispersive liquid–liquid microextraction based on solidification of a floating organic droplet

5. Ultrasound enhanced air-assisted surfactant liquid–liquid microextraction based on the solidification of an organic droplet for the determination of chromium in water, air and biological samples

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel fluorescent probe based imprinted polymer-coated magnetite for the detection of imatinib leukemia anti-cancer drug traces in human plasma samples;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-07

2. Chromatographic and mass spectrometric analytical strategies for profiling tyrosine kinase inhibitors in biological samples;Microchemical Journal;2024-06

3. Ultrasensitive detection of imatinib in human serum using a gold-based paper sensor;Journal of Chromatography B;2024-02

4. Developing an exclusive sensor based on molecularly imprinted polymer/Multi-walled carbon nanotubes/Fe3O4@Au nanocomposite for the selective determination of an anti-cancer drug imatinib;Chemosphere;2023-12

5. Pretreatment and analysis techniques development of TKIs in biological samples for pharmacokinetic studies and therapeutic drug monitoring;Journal of Pharmaceutical Analysis;2023-11